Z36.84
Encounter for antenatal screening for fetal lung maturity
Clinical Classification Guidelines
Medical Intelligence & Overview
Antenatal screening for fetal lung maturity is a medical procedure performed during pregnancy to assess the development and readiness of a fetus's lungs for breathing outside the womb. This screening is essential for expecting mothers whose pregnancies may be at risk for preterm birth or other complications that could affect the baby's lung function after birth. By evaluating lung maturity, healthcare providers can make informed decisions about delivery timing, especially in pregnancies where early delivery is considered or unavoidable.
Causes & Symptoms
Clinical Causes: Risk factors for preterm labor or early delivery History of previous premature birth Maternal health conditions affecting fetal development (e.g., diabetes, hypertension) Oligohydramnios (low amniotic fluid levels) Multiple pregnancies (twins, triplets, etc.) Pregnancies complicated by infections or placental issues Fetal growth restrictions or abnormal fetal imaging findings
Key Symptoms: Mother feeling increased discomfort or contractions Uncertain gestational age or concerns about early labor Presence of health conditions that may prompt closer fetal assessment No specific symptoms; screening is typically routine or based on risk factors
Diagnostic & Treatment
Diagnosis Path: The assessment of fetal lung maturity involves specific tests conducted on amniotic fluid obtained through amniocentesis. These tests include:
Treatment Protocols: Antenatal screening for fetal lung maturity does not involve treatment but serves as an essential diagnostic step. Following screening, healthcare providers determine the best course of action, which may include:
Clinical Advice & FAQs
Billing Guidance
Is Z36.84 a billable ICD-10 code?
Yes, Z36.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z36.84?
Clinical documentation must specify the nature of Encounter for antenatal screening for fetal lung maturity and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
